International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study
Authors:
- Larisa J. GeskinLarisa J. Geskin
- Bradley D. KwintaBKBradley D. Kwinta
- Tiffany J. Garcia-SaleemTGTiffany J. Garcia-Saleem
- Oleg E. AkilovOleg E. Akilov
- Paula A. EnzPEPaula A. Enz
- Emmanuella GuenovaEmmanuella Guenova
- Pablo L. Ortiz-RomeroPOPablo L. Ortiz-Romero
- Evangelia PapadavidEPEvangelia Papadavid
- Pietro QuaglinoPietro Quaglino
- Sima RozatiSRSima Rozati
- Connor J. StonesiferCSConnor J. Stonesifer
- Austin BurnsABAustin Burns
Open Access
- 12 November 2022
- journal article
- letter
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 88 (4) , 935-937
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemicJournal of the American Academy of Dermatology, 2020
- Management of primary cutaneous lymphoma patients during COVID‐19 pandemic: EORTC CLTF guidelinesJournal of the European Academy of Dermatology and Venereology, 2020